Belvedere Trading LLC Cardiff Oncology, Inc. Put Options Transaction History

Belvedere Trading LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	BUY	$1.22 - $1.66 $15,616 - $21,248	12,800 New	12,800 $17,000
Q2 2021 Jul 23, 2021	SELL	$6.65 - $10.04 $86,450 - $130,519	-13,000 Closed	0 $0
Q1 2021 Apr 27, 2021	SELL	$9.1 - $19.57 $45,500 - $97,850	-5,000 Reduced 27.78%	13,000 $120,000
Q4 2020 Feb 10, 2021	BUY	$12.02 - $24.71 $216,360 - $444,780	18,000 New	18,000 $324,000

12.3M

813K

91.1K

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $185M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.